Search
for

    Sort by

    Research 30 of 1000+

    1. Repurposing of approved cardiovascular drugs Journal of Translational Medicine · 2016 · 73 citations
    2. Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III Cardiology in Review · 2002 · 15 citations
    3. A perspective on small molecules targeting the renin–angiotensin–aldosterone system and their utility in cardiovascular diseases: exploring the structural insights for rational drug discovery and development RSC Medicinal Chemistry · 2025 · 6 citations
    4. Drugs and Hair Loss Dermatologic Clinics · 2012 · 54 citations
    5. Exploring pericyte and cardiac stem cell secretome unveils new tactics for drug discovery Pharmacology & Therapeutics · 2016 · 26 citations
    6. Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society The Journal of Clinical Endocrinology & Metabolism · 2010 · 815 citations
    7. The metabolic effects of drugs used for the treatment of polycystic ovary syndrome Journal of the Turkish-German Gynecological Association · 2013 · 2 citations
    8. Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO) Frontiers in Cardiovascular Medicine · 2025 · 3 citations
    9. Response to “The Role of Patient‐ and Drug‐Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System” Journal of Cosmetic Dermatology · 2025
    10. The use of anabolic androgenic steroids: A focus on polypharmacy Medicinski pregled · 2018
    11. An Overview of Harmful Effects of Polycystic Ovary Syndrome Journal of oncology research reviews & reports · 2021
    12. Síndrome de ovarios poliquísticos Polycystic ovary syndrome Interciencia médica · 2021
    13. Antioxidants and Mitochondrial Bioenergetics Elsevier eBooks · 2017
    14. Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women Human Reproduction Update · 2017 · 117 citations
    15. Insulin resistance and the long-term consequences of polycystic ovary syndrome Journal of Obstetrics and Gynaecology · 2011 · 29 citations
    16. Women’s Health Considerations for Lipid Management Cardiology Clinics · 2015 · 9 citations
    17. Metabolic Aspects of Polycystic Ovary Syndrome Postgraduate obstetrics & gynecology · 2015
    18. Androgenetic Alopecia From A to Z Springer eBooks · 2022
    19. Polycystic Ovary Syndrome in adolescents: an update Italian journal of gynaecology & obstetrics · 2020
    20. New drugs: Agalsidase beta Australian Prescriber · 2004
    21. New drugs: Iobenguane sulfate Australian Prescriber · 2004
    22. New drugs: Agalsidase alfa Australian Prescriber · 2004
    23. Cytostatics and immunosuppressive drugs Side effects of drugs annual · 1989
    24. Review of Cardiovascular Findings in Humans Treated with Minoxidil Toxicologic Pathology · 1989 · 28 citations
    25. Cardiovascular toxicity of minoxidil in the marmoset Toxicology Letters · 2008 · 15 citations
    26. A Nano-Pharmaceutical Formula of Quercetin Protects from Cardiovascular Complications Associated with Metabolic Syndrome Frontiers in Pharmacology · 2021 · 16 citations
    27. Signaling pathways in the mechanisms of drug action Fitoterapia · 2025
    28. Potential use of the Asteraceae family as a cure for diabetes: A review of ethnopharmacology to modern day drug and nutraceuticals developments Frontiers in Pharmacology · 2023 · 17 citations
    29. Guidelines for perioperative antithrombotic therapy in hair restoration surgery: management of patients with coronary heart disease, mechanical heart valve, and atrial fibrillation Hair transplant forum international · 2012 · 3 citations
    30. The prevalence and management of side effects of lithium and anticonvulsants as mood stabilizers in bipolar disorder from a clinical perspective International Clinical Psychopharmacology · 2013 · 65 citations